Does the interval from melphalan administration to infusion of hematopoietic stem cells affect outcomes after autologous transplantation in multiple myeloma?
Elsevier ·
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Does the interval from melphalan administration to infusion of hematopoietic stem cells affect outcomes after autologous transplantation in multiple myeloma?. // Hematology, Transfusion and Cell Therapy. – URL: https://www.sciencedirect.com/science/article/pii/S2531137926002804?dgcid=rss_sd_all
Does the interval from melphalan administration to infusion of hematopoietic stem cells affect outcomes after autologous transplantation in multiple myeloma?. Hematology, Transfusion and Cell Therapy. https://www.sciencedirect.com/science/article/pii/S2531137926002804?dgcid=rss_sd_all
“Does the interval from melphalan administration to infusion of hematopoietic stem cells affect outcomes after autologous transplantation in multiple myeloma?.” Hematology, Transfusion and Cell Therapy.
@article{article48021,
title = {Does the interval from melphalan administration to infusion of hematopoietic stem cells affect outcomes after autologous transplantation in multiple myeloma?},
journal = {Hematology, Transfusion and Cell Therapy},
url = {https://www.sciencedirect.com/science/article/pii/S2531137926002804?dgcid=rss_sd_all}
}